Clinical trials
Recruiting trials in Norway
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
675 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 5 |
| 2013 | 6 |
| 2014 | 7 |
| 2015 | 4 |
| 2016 | 25 |
| 2017 | 6 |
| 2018 | 15 |
| 2019 | 20 |
| 2020 | 31 |
| 2021 | 45 |
| 2022 | 43 |
| 2023 | 88 |
| 2024 | 133 |
| 2025 | 148 |
| 2026 | 88 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 675 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Oslo University Hospital | 104 |
| Haukeland University Hospital | 41 |
| Norwegian University of Science and Technology | 38 |
| St. Olavs Hospital | 25 |
| University Hospital, Akershus | 19 |
| Merck Sharp & Dohme LLC | 18 |
| University Hospital of North Norway | 15 |
| Vestre Viken Hospital Trust | 14 |
| Diakonhjemmet Hospital | 11 |
| University of Oslo | 11 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Myeloma | 22 |
| Obesity, Morbid | 22 |
| Colorectal Neoplasms | 19 |
| Neoplasms | 19 |
| Mental Disorders | 14 |
| Breast Neoplasms | 13 |
| Heart Failure | 13 |
| Stroke | 12 |
| Anxiety Disorders | 11 |
| Endometrial Neoplasms | 11 |
Trials
Showing 26 to 50 of 675. Each trial links to its page on Pharma Observatory.
575 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.